Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
and thank you it's a good morning
00:00:02
everyone I'm a medical student and i
00:00:04
will present you my mustard is so and in
00:00:09
Europe where in Europe approximately
00:00:13
530,000 Europeans our own method and
00:00:16
upgrade maintenance treatment with the
00:00:20
eighty percent receiving methoden in
00:00:23
2005 all that i conducted the study here
00:00:26
in Zurich and reporting an incidence of
00:00:28
newborn exposed to that end of 7 and
00:00:30
five thousand verse engineered during
00:00:33
the past years where we had around 24
00:00:35
babies 4,000 birth that were exposed to
00:00:39
methoden of those children 52 95%
00:00:44
require treatment for neon adopting
00:00:46
singam concerning the long-term never
00:00:50
knew developmental outcomes
00:00:52
some studies have found that in fact
00:00:55
that infants have motor development
00:00:58
compared to control children and the
00:01:01
link between methods and models and
00:01:04
infant mental outcome is still subject
00:01:06
to controversy specifically the effects
00:01:11
of the dosage of methoden on infants
00:01:14
outcome is still subject to controversy
00:01:16
while some studies have found higher
00:01:20
method in those to be related with more
00:01:22
7-ounce other studies have not found
00:01:25
this relationship and to Ireland to our
00:01:28
knowledge the relationship between
00:01:29
methanol those and children laters
00:01:32
development outcome has not been
00:01:34
investigated yet so the objective our
00:01:37
study was to determine the effects of
00:01:39
method and maintenance treatment on at
00:01:42
the outcomes and narrative movement and
00:01:44
feel the two years of life and study the
00:01:47
relationship between methanol middle and
00:01:49
those and the children outcomes so we
00:01:52
perform a retrospective analysis from a
00:01:55
good study that they were collected from
00:01:57
52 children's Madeline and
00:02:00
characteristic adverse were analyzed
00:02:03
mental motor functioning of those
00:02:06
children was assessed at six months and
00:02:08
18 to 24 months old
00:02:11
love with the standards better test the
00:02:13
Bailey scale of infant development the
00:02:15
second edition which give us a mental
00:02:17
development index and the cycle modem
00:02:19
psychomotor development index both score
00:02:23
our normal if they're above 85 so most
00:02:28
of our patients where is with the second
00:02:31
edition of Bailey but some of them with
00:02:33
the third edition of bailey so since
00:02:35
they exist the difference between the
00:02:37
tradition we could not use the infant's
00:02:40
SS with the third edition of bailey for
00:02:43
the development of analysis but for the
00:02:45
rest we use all the 52 patient's so the
00:02:49
result of the analysis showed that
00:02:50
mothers mean age was 31 years old the
00:02:54
main method and those was 81 me 2 grand
00:02:56
payday we get the guys method in those
00:02:58
in loaders and hiders with a cut-off of
00:03:00
70 milligrams pretty there was an equal
00:03:04
distribution between of my idols and
00:03:07
lows in the motors and the means to
00:03:10
economic status core was high and
00:03:12
correspond therefore to a low
00:03:13
socio-economic seduce concerning
00:03:16
substance use 20 feet twenty-six percent
00:03:19
of murder consume only method and and
00:03:22
the other the rest and meditating 11
00:03:26
more drug on more or more
00:03:28
here you can see the natal
00:03:30
characteristics so 13 infants were born
00:03:33
preterm the mean birthweight was 2665
00:03:38
grams approx more than ninety percent
00:03:42
require treatment for the nests with
00:03:45
them in duration of treatment of 52 days
00:03:47
and Amina length of hospitals day of
00:03:51
more than two months as you can see we
00:03:54
found a positive relationship between
00:03:56
mattelmead and O's and the duration of
00:03:58
an ass and the length of hospitality
00:04:01
looking out to the psychomotor
00:04:04
development of this infant the mean ask
00:04:08
at six months the mean mvi was 88 with a
00:04:12
43-percent that showed a mental delay
00:04:15
and the mean BDI was 76 with a most of
00:04:19
the pic most of the patients were delay
00:04:23
here you can see that we found a
00:04:25
negative relationship between the
00:04:27
mathematician and those and the PDI at
00:04:30
six months but not with the MDA at 18 to
00:04:35
24 months of H concerning the MDA in the
00:04:38
pinky I almost out of the patient where
00:04:41
the LA and the other half were within
00:04:43
normal limits no relationship where
00:04:45
found between them a ton of those and
00:04:47
the MDI and the pbi at this age so as
00:04:52
discussed before two groups reformed one
00:04:55
loaders and one hydros with the cutoff
00:04:57
of 70 milligrams per day matter now and
00:05:00
then a characteristic where compare so
00:05:03
it's important to know that
00:05:04
socioeconomic status was similar in both
00:05:07
group mother's where a older in the
00:05:11
hydros group small just as an age was
00:05:15
more frequent in the hiders group and in
00:05:18
comparison to the Lotus group the
00:05:19
highest group has a longer treatment for
00:05:22
NASA and longer hospital stays and
00:05:26
psychomotor abilities were also compared
00:05:30
according to the method and those at six
00:05:32
months the MDA of both group will little
00:05:35
bit still in the normal limits and the
00:05:37
mean median score where load then the
00:05:40
normative mean singles group at 18 to 24
00:05:45
months we observed the same trend with
00:05:47
the PDA and the MDI mean score in the
00:05:50
low range in both group with seventy
00:05:53
percent of the infant in the hydras
00:05:55
group showing delay mental performance
00:05:57
so our results suggest that being born
00:06:00
to a mother receiving a methadone
00:06:02
maintenance treatment was associated
00:06:04
with clinical adverse 95 / 25 percent of
00:06:08
the children were treated for NASA and
00:06:10
the two first years of life never
00:06:11
development the outcome was lowered and
00:06:13
the normative mean with motor abilities
00:06:15
more being more affected than cognitive
00:06:19
competence higher methanol those were
00:06:21
associated with SGA longer treatment for
00:06:25
NASA and longer infant hospitals day and
00:06:28
the mental delayed from it add movement
00:06:31
of labour from excuse me at two years
00:06:33
old
00:06:34
thank you for your attention

Share this talk: 


Conference program

Welcome Words
M. Roth-Kleiner, R. Arlettaz Mieth
10 Jan. 2017 · 9:33 a.m.
Short Reports Introduction
E. Giannoni, T. Karen, Resp. Lausanne, Zürich
10 Jan. 2017 · 9:38 a.m.
Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:39 a.m.
Q&A - Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:44 a.m.
Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:47 a.m.
Q&A - Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:54 a.m.
Parechovirus Infection: A Rare Cause of Neonatal Encephalitis (in French)
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 9:59 a.m.
Q&A - Parechovirus Infection: A Rare Cause of Neonatal Encephalitis
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 10:04 a.m.
Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:17 a.m.
Q&A - Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:25 a.m.
Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:27 a.m.
Q&A - Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:34 a.m.
Introduction to Christoph Berger's Presentation
C. Kind, R. Gerull, Resp. St.Gallen, Bern
10 Jan. 2017 · 10:37 a.m.
Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 10:40 a.m.
Q&A - Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 11:15 a.m.
Introduction to Eric Giannoni's Presentation
R. Pfister, S. Kämpfen, Resp. Geneva, Basel
10 Jan. 2017 · 11:44 a.m.
Sepsis, Antibiotics and Resistances: Where Are We?
Christoph Bührer, Berlin
10 Jan. 2017 · 2:21 p.m.
Use and Abuse of Antibiotics in Neonatology
Martin Stocker, Lucerne
10 Jan. 2017 · 2:50 p.m.
Panel Discussion : Controversies on Use of Antibiotics in Neonatology
Martin Stocker, Christoph Berger, Eric Giannoni, Christoph Bührer
10 Jan. 2017 · 3:10 p.m.
Introduction to Christoph Bührer's Presentation
Romaine Arlettaz Mieth , Neonatologist, Zürich, President of the Organizing Committee
10 Jan. 2017 · 3:47 p.m.
Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 3:48 p.m.
Q&A - Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 4:16 p.m.
SwissNeoDose Project
Marc Pfister, Ped Pharmacology, UKBB
10 Jan. 2017 · 4:20 p.m.
Awards (Case of the Year; Milupa; Best Poster Case Report; Best Oral Short Presentation) & Closing Comments
Matthias Roth-Kleiner, CHUV, President of the SSN
10 Jan. 2017 · 4:30 p.m.